Jul 29
|
Vivos Inc. Provides IDE Submission Status Update – Conversion to Pre-Sub Filing Accepted by the FDA
|
Dec 20
|
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation
|
Aug 7
|
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics
|